BREAKING NEWS: Brazil January Industry Output Rises the Most Since June, 2013

Bloomberg - Home Search
Celgene Corp (CELG:US)
update Mar 3
118.47 -1.84 (-1.53%)
High 120.19
Low 116.34
Open 119.99
Volume 6360692
Time Mar 3
intra-day chart
High 125.45
Low 66.85
P/E 46.31
Return +46.41%
Mkt Cap 94.846 B
one year chart
Company Profile
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.